Tablet splitting: A review of the clinical and economic outcomes and patient acceptance

Consultant Pharmacist

Volumn 27, Issue 6, 2012, Pages 421-430

  Freeman, Maisha Kelly ^a   White, Whitney ^a   Iranikhah, Maryam ^a  

^a SAMFORD UNIVERSITY   (United States)

Author keywords

Clinical outcomes; Economic impact; Medication; Pharmacy benefit management; Tablet splitting

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; LISINOPRIL; METOPROLOL; MEVINOLIN; MIRTAZAPINE; NEFAZODONE; OLANZAPINE; PAROXETINE; PRAVASTATIN; RISPERIDONE; ROSUVASTATIN; SERTRALINE; SILDENAFIL; SIMVASTATIN; SOTALOL; VENLAFAXINE; WARFARIN;

COST CONTROL; DISORDERS OF CHOLESTEROL METABOLISM; ECONOMIC EVALUATION; ECONOMICS; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERTENSION; MEDLINE; MENTAL DISEASE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TABLET PROPERTY; TABLET SPLITTING;

COST SAVINGS; DRUG COSTS; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; TABLETS; TREATMENT OUTCOME;

EID: 84863084658     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2012.421     Document Type: Review

References (25)

1. Revisiting tablet splitting. Drug Management Forum. Available at http://www.drugmanagementforum.com/forum/managed-care-pharmacy-administrative- issues/8774-revisiting-tablet-splitting.html. Accessed July 23, 2011.
2. San Francisco Chronicle examines use of pill-splitting programs by health insurers. Kaiser Health News. Available at http://www.aamedya.com/health/ linkac.php?id=http://www.kaisernetwork.org. Accessed March 26, 2011.
3. VISN Tablet Splitting Medications. Available at www1.pacific.edu/ ~npettit/Tablet-Split-List.doc. Accessed June 10, 2011.
4. VHA Formulary Management Process. Available at http://www.pbm.va.gov/ directive/vhadirective.pdf. Accessed June 10, 2011.
5. APhA Resource: Practice. Tablet splitting: evaluating appropriateness for patients. J Am Pharm Assoc 2004;44:324-5.
6. Pharmacists survey gives insight into the impact of the economic downturn on patients, pharmacy practice, and their communities. Available at http://www.pharmacist.com/AM/Template.cfm?Section=News-Releases2&template=/ CM/ContentDisplay.cfm&ContentID=18987. Accessed March 28, 2011.
7. Tablet splitting: a risky practice. FDA Consumer update. Available at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm171492.htm. Accessed March 28, 2011.
8. Stafford RS, Radley DC. The potential of pill splitting to achieve cost savings. Am J Manag Care 2002;8:706-12. (Pubitemid 34987577)
9. Choe HM, Stevenson JG, Streetman DS et al. Impact of patient financial incentives on participation outcomes in a statin pill-splitting program. Am J Manag Care 2007;13:298-304. (Pubitemid 46983139)
10. Adelman JU, Adelman LC, Freeman MC et al. Cost consideration of acute migraine treatment. Headache 2004;44:271-85. (Pubitemid 38436693)
11. Hill SW, Varker AS, Karlage K et al. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm 2009;15:253-61.
12. Bachynsky J, Wiens C, Melnychuk K. The practice of splitting tablets: cost and therapeutic aspects. Pharmacoeconomics 2002;20:339-46. (Pubitemid 34569367)
13. Newly-approved professional pharmacy services save time, money. http://media.alabama.gov/pr/pr.aspx?id=5314&t=1. Accessed July 10, 2011.
14. Duncan MC, Castle SS, Streetman DS. Effect of tablet splitting on serum cholesterol concentrations. Ann Pharmacother 2002;36:205-9. (Pubitemid 34126808)
15. Gee M, Hasson NK, Hahn T et al. Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. J Manag Care Pharm 2002;8:453-8.
16. Rindone JP. Evaluation of tablet-splitting in patients taking lisinopril for hypertension. JCOM 2000;7:22-4.
17. Weissman EM, Dellenbaugh C. Impact of splitting risperidone tablets on medication adherence and on clinical outcomes for patient with schizophrenia. Psychiatr Serv 2007;58:201-6. (Pubitemid 46340463)
18. Wolfgang SA. Olanzapine in whole, not half, tablets for psychosis from Alzheimer's dementia. Am J Health Syst Pharm 1999;56:2245-6. (Pubitemid 29531734)
19. Fawell NG, Cookson TL, Scranton SS. Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance. Am J Health Syst Pharm 1999;56:2542-5. (Pubitemid 30013949)
20. Look KA, Mott DA, Kreling DH et al. Economic impact of pharmacist-reimbursed drug therapy modification. J Am Pharm Assoc 2011;51:58-64.
21. Dormuth CD, Schneeweiss S, Brookhart AM et al. Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis. Open Med 2008;2:1-6.
22. Miller DP, Furberg CD, Small RH et al. Controlling prescription drug expenditures: a report of success. Am J Manag Care 2007;13:473-80. (Pubitemid 47301274)
23. Vuchetich PJ, Garis RI, Jorgensen AM. Evaluation of cost savings to a state Medicaid program following a sertraline tablet-splitting program. J Am Pharm Assoc 2003;43:497-502.
24. Dobscha SK, Anderson TA, Hoffman WF et al. Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center. Psychiatr Serv 2003;54:195-200. (Pubitemid 36752850)
25. Cohen CI, Cohen SI. Potential savings from splitting newer antidepressant medications. CNS Drugs 2002;16:353-8. (Pubitemid 34548202)